Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Anti-D (RHO) immunoglobulin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Anti-D (RHO) immunoglobulin 1,250units/1ml inj pfs
1405030A0AAABAB
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 1,500unit pdr & solv inj vials
1405030A0AAAIAI
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 1,500unit soln for inj vials
1405030A0AAARAR
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 1,500units/2ml inj pfs
1405030A0AAAJAJ
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 2,500unit inj vials
1405030A0AAAPAP
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 250unit inj vials
1405030A0AAAMAM
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 5,000unit inj vials
1405030A0AAAQAQ
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Anti-D (RHO) immunoglobulin 500unit inj vials
1405030A0AAANAN
|
Anti-D (RHO) immunoglobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.